Scientists propose in Nature blocking a molecule that drives inflammation and organ damage in Gaucher and maybe other lysosomal storage diseases as a possible treatment with fewer risks and lower costs than current therapies.
An international research team led by Cincinnati Children’s Hospital Medical Center, which also included investigators from … Continue reading
Brückenkopf GmbH recently interviewed with Mr. Ketan Munjani, Marketing and Sales Manager at JK Medirise.
(Q: Question from Brückenkopf GmbH / A: Answer from Mr. Ketan Munjani by JK Medirise)
Q: Mr. Munjani, what is your current portfolio? We understand that your company is a reputable … Continue reading
Brückenkopf recently interviewed with Mr. Dr. Izak Daizade M.D – founder and R&D Manager at UNFO Med, who offers innovative device to treat newborns afflicted with congenital foot deformities.
(Q: Question from Brückenkopf GmbH / A: Answer from Mr. Dr. Izak Daizade M.D by UNFO Med)
Q: Mr. Dr. … Continue reading